Tandem Diabetes CareTNDM
About: Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Employees: 2,400
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
784% more call options, than puts
Call options by funds: $135M | Put options by funds: $15.3M
75% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 36
36% more repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 91
11% more capital invested
Capital invested by funds: $2.67B [Q1] → $2.96B (+$292M) [Q2]
9% more funds holding
Funds holding: 288 [Q1] → 315 (+27) [Q2]
1.06% less ownership
Funds ownership: 114.99% [Q1] → 113.93% (-1.06%) [Q2]
50% less funds holding in top 10
Funds holding in top 10: 4 [Q1] → 2 (-2) [Q2]
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
9 analyst ratings
Goldman Sachs David Roman 50% 1-year accuracy 3 / 6 met price target | 37%upside $46 | Neutral Initiated | 4 Oct 2024 |
RBC Capital Shagun Singh 76% 1-year accuracy 44 / 58 met price target | 93%upside $65 | Outperform Initiated | 2 Oct 2024 |
Morgan Stanley Patrick Wood 67% 1-year accuracy 8 / 12 met price target | 34%upside $45 | Equal-Weight Maintained | 23 Sept 2024 |
Morgan Stanley Patrick Wood 67% 1-year accuracy 8 / 12 met price target | 34%upside $45 | Equal-Weight Initiated | 22 Aug 2024 |
Canaccord Genuity William Plovanic 41% 1-year accuracy 12 / 29 met price target | 69%upside $57 | Buy Initiated | 8 Aug 2024 |
Financial journalist opinion
Based on 7 articles about TNDM published over the past 30 days
